We've invested over 1.3 Million Dollars in Research
September 6, 2020 - The period for receiving Letters of Intent for the 2021 funding season has CLOSED. Invitations for full applications have been sent for the Peter Joseph Pappas Research Grants funding program, designed to accelerate preeclampsia research. The ultimate goal of this grant program is to drive research that will eliminate the delivery of pre-term babies as an intervention for severe preeclampsia, HELLP syndrome, and related hypertensive disorders of pregnancy. Named for the infant son of preeclampsia survivor Lauren Pappas and her husband Clement, the program seeks to award multiple grants totaling up to $200,000 each year.
Final applications are due via e-mail to PJPGrants@preeclampsia.org no later than October 9, 2020 at midnight (ET).
Read more about the Peter Joseph Pappas Research Grant Program.
Questions? Contact PJPGrants@preeclampsia.org
You can read about our 2020 awardees here and this year's full announcement here.
The Preeclampsia Foundation is temporarily suspending its Vision Grant Program for the 2020 season, as a result of the research challenges posed by the COVID-19 outbreak. Our preeclampsia community remains dedicated to catalyzing much-needed preeclampsia research, and we will keep you updated with new vision grant announcements as we navigate these difficult times. Please take care of those you hold most dear, and thank you for making the work of the Preeclampsia Foundation possible.
Questions? Contact VisionGrants@preeclampsia.org
EMPOWER (EMpowering Progress in Obstetric and Women's hEalth Research) was established to create partnerships between mentors and single sites or groups within low- and middle-income countries to improve clinical and health services research into the hypertensive disorders of pregnancy.
When available, funding is for a two-year research project. The immediate objective is the completion of a project designed by a local investigator and, when appropriate, the dissemination of the results of the study to change practice and improve care.
EMPOWER is a collaboration of the International Society for the Study of Hypertension in Pregnancy, the Preeclampsia Foundation, PRE-EMPT/Global Pregnancy Collaboration, and supporting organization New Zealand Action on Pre-eclampsia.
Please note: The EMPOWER program is currently on hold and no applications are being accepted at this time.
EMPOWER Program Announces 2016 Recipient
The Preeclampsia Foundation, along with its partners International Society for the Study of Hypertension in Pregnancy (ISSHP) and the PRE-EMPT/Global Pregnancy Collaboration (CoLab), announced the recipient of their EMPOWER Award for preeclampsia-related research at the opening ceremonies of the World Congress of ISSHP. Dr. Sarah Manyame, a physician-researcher with the Department of Obstetrics and Gynaecology at the University of Zimbabwe Parirenvatwa Group of Hospitals, was awarded $60,000 USD for her two-year project “Urine Biomarkers for Preeclampsia in High Risk Women.” Dr. James Roberts with the Magee-Womens Research Institute in Pittsburgh, Pennsylvania, will serve as Dr. Manyame’s mentor.
Questions? Contact empower@preeclampsia.org
Please contact us if you would like the Preeclampsia Foundation to help you recruit participants for a research study or focus group.
Answers to our most frequently asked questions about the registry
Everyone can play a role in preeclampsia research. Enroll Today login
The Preeclampsia Registry is a valuable resource that you can turn to when posing new questions, testing new hypotheses, and building study cohorts. As a “living database” that i...
According to the World Health Organization, preeclampsia is one of the least funded areas of research, especially when considered against Disability Adjusted Life Years (DALYs). The Preeclampsia Found...
The Letter of Intent period is CLOSED for the 2020 Peter Joseph Pappas Research Grants funding program. Decisions will be rendered in December 2020 and the next funding round will be announced next ye...
High Blood Pressure During Pregnancy May Be a Warning Sign of Life-threatening Condition World’s Leading Clinicians and Researchers to Discuss Best Practices for Predicting, Preventing, and M...
Melbourne, FL – December 30, 2020 – The Preeclampsia Foundation announces the recipients of its 2021 Peter Joseph Pappas Research Grants, a funding program designed to accelerate p...
Title: Vitamin D in the womb may be protective for babies born from pregnancies complicated by preeclampsia Article Title: Associations of Cord Blood Vitamin D and Preeclampsia With Offspring B...
August 6, 2020 – Melbourne, FL – The Preeclampsia Foundation is seeking Letters of Intent for the Peter Joseph Pappas Research Grants funding program, designed to accelerate preeclampsia r...
TREATMENT Results of a trial to test a new medication for preterm preeclampsia: the PRESERVE-1 Trial AJOG Preterm preeclampsia is a rare form of preeclampsia that occurs at 23-30 weeks of...